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consistent with scar tissue, without evidence of infection. She 
was prescribed a 3-PD base out Fresnel prism over the right 
eye, which relieved her diplopia in primary gaze. The patient 
was to consider surgery a year following the first operation, 
with the goal of achieving single binocular vision in primary 
gaze and improving enophthalmos.
DISCUSSION
Surgical repair of orbit fractures caused by endoscopic 
sinus surgery is technically demanding, both in achiev-
ing adequate exposure of large fractures and in retrieving 
lost muscles. In the largest series published on MR injuries 
from endoscopic sinus surgery, out of 30 cases, 8 involved 
transection of the MR.1 Five underwent surgery, with result-
ing improvement in primary ocular alignment in most cases 
but severely limited horizontal ductions. Conservative treat-
ment (observation or intravenous steroids) did not improve 
ocular alignment. In another series, 13 of 15 cases involved 
damage to the MR; none of them achieved fused vision in 
primary gaze after  surgery.2 While ocular alignment is often 
improved after surgery, the chances of fused vision in primary 
gaze are slim.
Previous reports have described using “hang-back 
sutures” to reattach the 2 ends of a transected muscle, reattach-
ing directly to sclera, or transposing the vertical recti. With the 
large distance between the 2 ends of muscle in this case and 
a poor prognosis for functional recovery, it was deemed that a 
bridging material would be the best way to reattach the muscle. 
Silicone retina bands have been used in strabismus surgery to 
elongate the superior oblique tendon, to weaken the superior 
oblique.3,4 Here, the band was used to replace the large piece of 
missing muscle. However, postoperatively, the patient developed 
a frozen globe, likely due to scar tissue formation. If the patient 
opts for another surgery, surgical options include a fat graft to 
improve enophthalmos and transposition of the vertical muscles 
toward the MR or autogenous periosteal flaps to tether the globe 
in a fixed primary position.
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Abstract: A 12-year-old girl had a 6-year history of a large 
soft-tissue mass in her left orbit. The tumor biopsy was 
previously performed elsewhere when she was 7 years old, 
but no treatment was offered at that time. Later, the tumor 
was completely excised, and histologic examination revealed 
a mesenchymal neoplasia with typical hemangiopericytoma 
features. At 9 months of follow up, no evidence of local 
recurrence or metastasis was seen.
In 1942, Stout and Murray1 described a mesenchymal neo-plasm that they named hemangiopericytoma (HPC) because 
they considered that the tumor cells derived from pericytes. 
According to the authors, HPC is a tumor composed of groups 
of round to spindle cells surrounding endothelium-lined 
branching vessels that show a staghorn appearance.1
Orbital tumors with the histologic appearance described 
by Stout and Murray are extremely rare in children. In the 
present report, we describe the case of a girl with a 6-year 
history of a large orbital lesion, which had all the histologic 
features considered to be typical of HPC, and we review the 
literature on this type of orbital neoplasm in children.
CASE REPORT
A 12-year-old girl ws seen with a painless, large mass in 
the inferior aspect of the left orbit. The left eye was clearly dis-
placed upward, but eye motility was normal (Fig. 1, top). MRI 
of the orbits showed a well-defined, large, orbital mass, in the 
left inferior orbital quadrant, without bone erosion (Fig. 2).
The tumor was completely excised through an inferior 
eyelid crease approach to the orbit. On gross examination, 
the tissue fragment measured 3.0  2.5  1.0 cm and was 
partially covered by adipose tissue of normal appearance. 
The cut surfaces showed a grossly round, well-delimited, 
firm, yellowish brown lesion measuring 2.0 cm in diameter. 
Microscopic examination revealed a multilobulated tumor 
with distinct small perivascular nodules outside the main 
tumor mass (Fig. 3, middle). A ramifying vasculature in a 
staghorn vascular pattern was seen, with partially hyalinized 
vessels (Fig. 3, top). The cells around the vessels were mostly 
round and showed fine chromatin without atypia. Collagen 
deposition, significant mitotic activity, or necrosis was not 
found. There was one mitotic figure per 10 high-power fields. 
Focally, there was an area of myxoid appearance. The reticulin 
stain revealed a meshwork of reticulin surrounding the neo-
plastic cells. The immunohistochemical profile of the lesion 
showed positivity of the neoplastic cells for vimentin, CD34 
(Fig. 3, bottom), smooth muscle actin (1A4), HHF-35, and 
calponin. The surgical margins were free of tumor. No com-
plications occurred after the surgical procedure. Nine months 
after excision, no evidence of local recurrence or metastases 
was found.
DISCUSSION
Pericytes are elongated periendothelial cells found in 
almost all capillaries and in small venules and arterioles.2 They 
have myoid features reflected in numerous cytoplasmic micro-
filaments resembling actin- and myosin-containing muscle 
fibers and immunopositivity for a-smooth muscle actin.3,4 For 
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this reason, pathologists who evaluate CD341 tumors con-
sider the presence of a meshwork of pericellular reticulin and 
poorly differentiated myofibrils within the neoplastic stromal 
cells to be important histologic features for the diagnosis of 
HPC.1 However, over the years, it became clear that a variety 
of different tumors might display the histologic characteris-
tics that once were considered to be typical of HPC.5 Solitary 
fibrous tumor (STF) is the most cited example and, although 
FIG. 1. Clinical aspect of the patient. Top, Preoperative pre-
sentation. Large mass protruding through the inner aspect of 
the lower eyelid. Notice the scar of a previous biopsy and the 
vertical eye dystopia. Bottom, Good result after an infraciliary 
incision, with a slight residual vertical eye dystopia.
FIG. 2. Magnetic resonance imaging. Left, Axial T2-weighted 
slice showing a multilobulated large mass on the orbital floor. 
Right, The lesion is intensely enhanced on T1-weighted coronal 
slice after contrast administration.
some morphologic criteria are used to differentiate HPC from 
STF (Table), a general trend is now to consider both tumors 
as just one entity.6,7 In some cases, it is almost impossible to 
distinguish between STF and HPC morphologically and/or 
immunohistochemically.8
Because the precise line of differentiation shown by 
HPC/SFT is still unclear, our case could be classified as 
HPC/SFT (cellular form), even though it presented mark-
ers that indicate myoid differentiation. These mesenchymal 
neoplasms are extremely rare in childhood. We found only 
9 tumors classified as HPC9–17 and 2, as STF18,19 in patients 
younger than 10 years. They usually have a benign course, 
even though those that have cytologic atypia, necrosis, and 
4 or more mitotic figures per 10 high-power fields can be 
locally aggressive or metastasize.11,15 In addition, some 
tumors can cause life-threatening hemorrhages.16
FIG. 3. Top, Dense cellularity and staghorn vascular pattern in 
hemangiopericytoma (hematoxylin-eosin, 100); middle, mul-
tilobulated tumor with distinct perivascular small nodules out-
side the main tumor mass (hematoxylin-eosin, 25); bottom, 
diffuse positivity for CD34 in endothelial cells and cells  
surrounding blood vessels (immunohistochemistry, 200).
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 Criteria used for the histopathologic differentiation 
between solitary fibrous tumors and hemangiopericytomas
Features
Solitary fibrous 
tumors Hemangiopericytomas
Stroma Collagenous 1111 Collagenous 1/11
Cellularity 1/11 Cellularity 1111
Spindle cells 111 Spindle cells 1/11
Round cells 1 Round cells 1111
Vasculature Staghorn pattern  
1/11
Staghorn pattern 
1111
CD34 1  
 
Virtually all cases 
(vessels and 
stromal cells)
Most cases (vessels and 
stromal cells) 
Vimentin 1111 1111
Actin 2/1 1
Smooth muscle 
actin
1 11
Desmin — —
CD 99 111 111
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Abstract: Plasmacytomas are plasma cell neoplasms that 
rarely involve ocular adnexal tissues as a primary lesion or 
secondary manifestation of plasma cell myeloma. Only one 
case of plasmacytoma involving the lacrimal drainage system, 
to our knowledge, is described in the literature. The clinical 
presentation of ocular adnexal primary plasmacytoma 
typically relates to its mass effect. In this clinicopathologic 
report, we describe an unusual presentation of primary 
plasmacytoma of the lacrimal canaliculus as infectious 
canaliculitis.
Extramedullary plasmacytoma (EMP) is malignancy of plasma cell origin in soft tissue. EMP can occur as a solitary mass 
(primary EMP) or as a secondary manifestation of systemic 
plasma cell neoplasia such as multiple myeloma.1 Ophthalmic 
involvement by EMP is rare, constituting only up to 6% of ocu-
lar lymphoproliferative lesions.2 Data on the ophthalmologic 
manifestations of primary EMP are limited to case reports, in 
which EMP is typically described as an indolent mass, localized 
to the orbit or conjunctiva.1 In this case report, we describe an 
unusual presentation of primary EMP associated with infectious 
canaliculitis.
CASE REPORT
A 78-year-old man presented with a 3-year history of tear-
ing, redness, and purulent discharge emanating from the left lower 
punctum. Examination of the affected region failed to reveal pal-
pable mass in the lacrimal sac area or obstruction on irrigation of 
the left upper punctum. Thus, clinical findings were interpreted as 
consistent with infectious canaliculitis (Fig. 1). Incision and drain-
age of the left lower canaliculus were performed. Upon opening 
the canaliculus, examination revealed an intracanalicular tumor, 
which was red and polypoid in nature, and numerous luminal 
white-yellow, large concretions. The concretions were removed, 
and the mass was debulked, with preservation of the canaliculus, 
which was patent on saline irrigation. Following pathologic diag-
nosis of plasmacytoma, the patient underwent oncologic work-up 
for plasma cell proliferative and lymphoproliferative disease, 
which was negative. The patient underwent a total dose of 41 Gy 
of external beam radiotherapy to the affected area while being 
maintained on topical lubricating and corticosteroid drops. Six 
months later, the patient has no clinical evidence of recurrent dis-
ease, as evidenced by lack of epiphora, lacrimal system obstruc-
tion, palpable mass, or recurrence of canaliculitis.
Histopathologic evaluation of the biopsied tissue revealed 
a collection of mildly atypical plasma cells in the canalicular 
stroma (Fig. 2). Immunohistochemical evaluation showed that the 
atypical cells expressed plasma cell marker CD138 and weakly 
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